publicações selecionadas
-
artigo académico
- In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer. RSC Medicinal Chemistry. 2024
- Synthesis and Biological Evaluation of Novel Chromeno[2,3-d]Pyrimidinones as Agents for Triple Negative Breast Cancer Treatment. European Journal of Medicinal Chemistry (IF 7.08, Q1 Chemistry, Organic). 2023
- Selective cytotoxicity of Portuguese propolis ethyl acetate and butanol fractions towards renal cancer cells. Biomolecules. 2022
- Imidazolylpyrrolone-Based Small Molecules as Anticancer Agents for Renal Cell Carcinoma. Chemistry - A European Journal. 2022
- New chromene-based compounds as anticancer agents for triple-negative breast cancer therapy. Euroepan Journal of Medicinal Chemistry. 2022
- Renal cell carcinoma therapy: Current and new drug candidates. Drug Discovery Today. 2022
- In vivo efficacy studies of chromene-based compounds in triple-negative breast cancer: A systematic review. European Journal of Pharmacology. 2020
-
artigo de revista
- Selective Cytotoxicity of Portuguese Propolis Ethyl Acetate Fraction towards Renal Cancer Cells. Biomolecules. 2022
- Unravelling the anticancer potential of functionalized chromeno[2,3-b]pyridines for breast cancer treatment. Bioorganic Chemistry. 2020
- Exploitation of New Chalcones and 4H-chromenes as Agents for Cancer Treatment. European Journal of Medicinal Chemistry. 2018
- Adenine Derivatives: Promising Candidates for Breast Cancer Treatment. European Journal of Organic Chemistry. 2018
-
capítulo de livro
-
documento
- Synthesis of imidazo-pyridines/diazepines and evaluation of their anticancer potential in renal cell carcinoma cell lines 2023
- New imidazole based scaffolds for the treatment of renal cell carcinoma 2023
- Biological characterization of novel chromeno[2,3-d]pyrimidinones as therapeutic approach for the treatment of triple-negative Breast Cancer 2023
- Chromene-based molecules: privileged scaffold for oncology drug development 2023
- Synthesis of chromene[2,3-b]pyridines and characterization of their anticancer potential for the treatment of breast cancer 2023
- In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer 2023
- New imidazole derivatives as anticancer agents for the treatment of renal cell carcinoma 2023
- Síntese de cromeno[2,3-b]piridinas e caracterização do seu potencial anticancerígeno para o tratamento do cancro da mama 2023
- Avaliação in vitro e in vivo de novos cromeno[2,3-d]pirimidinonas como agentes terapêuticos para o cancro da mama triplo-negativo 2023
- Chromen[2,3-b]pyridines: synthesis and evaluation of the anticancer potential for breast cancer treatment 2022
- A new lead compound for triple negative breast cancer therapy 2021
- New chromene derivatives: overcoming renal cell carcinoma drug resistance 2021
- A new therapeutic option for triple negative breast cancer 2021
- Novel therapy for renal cell carcinoma: overcoming drug resistance 2021
- Anti-cancer activity of Portuguese propolis fractions and isolated compounds 2021
- Renal anticancer activity of Portuguese propolis fractions and isolated compounds 2021
- Characterization of the biological activity of functionalized chromeno[2,3-b]pyridines for breast cancer treatment 2020
- New substituted 3,5-dihydro-4H-chromeno [2,3-d] pyrimidin-4-one: a promising strategy for breast cancer treatment 2020
- Unravelling the anticancer potential of novel compounds for breast cancer therapy 2020
- Characterization of the biological activity of functionalized chromeno[2,3b]pyridines for breast cancer treatment 2020
- New substituted 3,5-dihydro-4H-chromeno [2,3-d] pyrimidin4-one: a promising strategy for breast cancer treatment 2020
- New chromene derivatives: unravelling the molecular mechanisms for breast cancer treatment 2019
- Synthesis of imidazole derivatives and evaluation of the anticancer potential on renal cell carcinoma 2019
- Chromene derivatives: a new strategy to overcome renal cancer resistance 2019
- Chromene derivatives: a new strategy to overcome renal cancer resistance. 2019
- Exploitation of novel chromene derivatives for breast cancer treatment 2019
- Synthesis and biological activity of new anticancer agents for breast cancer treatment 2019
- Exploitation of novel chromene derivatives for breast cancer treatment. 2019
- New chromene-based molecules for renal cell cancer therapy 2019
- New molecules based on chromene moiety as candidates for renal cell carcinoma therapy 2019
- Novas moléculas baseadas na unidade de cromeno como candidatas à terapia do carcinoma das células renais (CCR). 2019
- Síntese e atividade biológica de novos agentes anticancerígenos para o tratamento do cancro da mama. 2019
- New chromene derivatives: Unraveling the molecular mechanisms for breast cancer therapy 2019
- Chromene-based compounds as candidates for renal cell cancer treatment 2019
- Chromene-based compounds as candidates for renal cell cancer treatment. 2019
- New chromene derivatives: Unraveling the molecular mechanisms for breast cancer therapy. 2019
- Biological activity of novel targeted inhibitors for renal cell cancer therapy 2019
- Biological activity of novel targeted inhibitors for renal cell cancer therapy. 2019
- In vitro and in vivo evaluation of new chromene derivatives as potent anticancer agents 2019
- In vitro and in vivo evaluation of new chromene derivatives as potent anticancer agents. 2019
- Synthesis of imidazo-pyridine derivatives for mTOR inhibition 2019
- Chromene-based molecules as targeted inhibitors for renal cell cancer therapy 2019
- Chromene-based molecules as targeted inhibitors for renal cell cancer therapy. 2019
- New chromene-based molecules as microtubule destabilizers and pro-apoptotic agents in cancer 2018
- Chemical and biological characterization of chalcones and 4H-chromenes: exploitation as anticancer agents 2018
- Chemical and biological characterization of chalcones and 4H-chromenes: exploitation as anticancer agents. 2018
- Unraveling the anticancer molecular mechanisms of new chromene-based drugs 2018
- Discovery of chromene-based molecules as apoptosis-inducers by G2/M cell-arrest 2018
- Discovery of chromene-based molecules as apoptosis-inducers by G2/M cell-arrest. 2018
- Unraveling the anticancer molecular mechanisms of new chromene-based drugs. 2018
- Chromene-based drug candidates for cancer treatment 2018
- Chromene-based drug candidates for cancer treatment. 2018
- New chromene-based drug candidates for cancer treatment 2017
- Chromene derivatives as anticancer agents: synthesis and biological evaluation 2016
- Chromene derivatives as anticancer agents: synthesis and biological evaluation. 2016
-
teses
- Characterization of the anticancer efficacy and safety profiles of novel synthetic compounds 2022
- New chromene-based drug candidates for cancer treatment 2017
- New chromene-based drug candidates for cancer treatment 2016
- Obesity effect on zebrafish (Danio rerio) retina and brain neurogenesis: role of genistein 2014